Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

NCT02867839 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped The number of patients enrolled was much less than expected

Conditions

Gastric Cancer

Interventions

DRUG: Oxaliplatin plus S-1
DRUG: S-1 only

Sponsor

Peking University Cancer Hospital & Institute